Healthcare systems and the various involved entities increasingly encounter the need to access data from real clinical practice. These data are essential, especially when introducing new treatment or diagnostic modalities to clinical practice.
According to current Slovak methodical guidelines, real data are preferred also in the preparation of pharmacoeconomic analyses. Real data may include clinical and economic data, but also data provided by patients themselves
Interested in our services?
We are happy to answer any questions you may firstname.lastname@example.org
We look forward to your visit.Where to find us
Do you want to receive the latest drug policy information by e-mail?
Our Pharm-Info service gives you access to all the latest information on registration, categorization and drug policy legislation in Slovakia.Contact us